Defunct Company
Total Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
936
NCT00753220
Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 31, 2009
Completion: Dec 31, 2011
NCT01214876
Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires
Phase: N/A
Role: Collaborator
Start: Aug 31, 2010
Completion: Mar 31, 2011
NCT02391571
A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects
Phase: Phase 3
Start: Feb 28, 2015
Completion: Mar 31, 2015
NCT02401750
A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery
Start: Jun 30, 2015
Completion: Sep 30, 2015
NCT05642780
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Phase: Phase 2
Start: Jan 17, 2023
Completion: Dec 31, 2027